Insulet (PODD) Common Equity (2016 - 2025)
Insulet's Common Equity history spans 16 years, with the latest figure at $1.5 billion for Q4 2025.
- For Q4 2025, Common Equity rose 25.06% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, up 25.06%, while the annual FY2025 figure was $1.5 billion, 25.06% up from the prior year.
- Common Equity reached $1.5 billion in Q4 2025 per PODD's latest filing, up from $1.4 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.5 billion in Q4 2025 to a low of $422.4 million in Q2 2022.
- Average Common Equity over 5 years is $804.0 million, with a median of $596.4 million recorded in 2021.
- Peak YoY movement for Common Equity: surged 892.03% in 2021, then fell 23.68% in 2022.
- A 5-year view of Common Equity shows it stood at $556.3 million in 2021, then fell by 14.36% to $476.4 million in 2022, then soared by 53.8% to $732.7 million in 2023, then soared by 65.36% to $1.2 billion in 2024, then increased by 25.06% to $1.5 billion in 2025.
- Per Business Quant, the three most recent readings for PODD's Common Equity are $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.5 billion (Q2 2025).